Clinical Trial Update: Randomized Study of Cisplatin-Etoposide Versus an Etoposide Regimen Without Cisplatin in Extensive Small-Cell Lung Cancer [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial comparing cisplatin-etoposide to an etoposide-only regimen in extensive small cell lung cancer has completed enrollment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Etoposide (Etoposide)

Snippet

Sponsor: European Lung Cancer Working Party | Conditions: Small Cell Lung Carcinoma, Extensive Disease | Phase 3 | Status: COMPLETED